Oral semaglutide for managing overweight and obesity [ID6188]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Setmelanotide for treating acquired hypothalamic obesity in people 4 years and older [ID6542]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Orforglipron for managing overweight and obesity [ID6516]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC